Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2001 Sep;56(Suppl 2):ii11–ii14.

Airway hyperresponsiveness and COPD mortality

J Vestbo, E Hansen
PMCID: PMC1765990  PMID: 11514701

Full Text

The Full Text of this article is available as a PDF (100.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Annesi I., Kauffmann F. Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men. Am Rev Respir Dis. 1986 Oct;134(4):688–693. doi: 10.1164/arrd.1986.134.4.688. [DOI] [PubMed] [Google Scholar]
  2. Anthonisen N. R., Connett J. E., Kiley J. P., Altose M. D., Bailey W. C., Buist A. S., Conway W. A., Jr, Enright P. L., Kanner R. E., O'Hara P. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994 Nov 16;272(19):1497–1505. [PubMed] [Google Scholar]
  3. Anthonisen N. R., Wright E. C., Hodgkin J. E. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986 Jan;133(1):14–20. doi: 10.1164/arrd.1986.133.1.14. [DOI] [PubMed] [Google Scholar]
  4. Benson M. K. Bronchial responsiveness to inhaled histamine and isoprenaline in patients with airway obstruction. Thorax. 1978 Apr;33(2):211–213. doi: 10.1136/thx.33.2.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Britton J., Pavord I., Richards K., Knox A., Wisniewski A., Wahedna I., Kinnear W., Tattersfield A., Weiss S. Factors influencing the occurrence of airway hyperreactivity in the general population: the importance of atopy and airway calibre. Eur Respir J. 1994 May;7(5):881–887. [PubMed] [Google Scholar]
  6. Burrows B., Bloom J. W., Traver G. A., Cline M. G. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med. 1987 Nov 19;317(21):1309–1314. doi: 10.1056/NEJM198711193172103. [DOI] [PubMed] [Google Scholar]
  7. Campbell A. H., Barter C. E., O'Connell J. M., Huggins R. Factors affecting the decline of ventilatory function in chronic bronchitis. Thorax. 1985 Oct;40(10):741–748. doi: 10.1136/thx.40.10.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cohen B. H. Is pulmonary dysfunction the common denominator for the multiple effects of cigarette smoking? Lancet. 1978 Nov 11;2(8098):1024–1027. doi: 10.1016/s0140-6736(78)92342-5. [DOI] [PubMed] [Google Scholar]
  9. Douma W. R., de Gooijer A., Rijcken B., Schouten J. P., Koëter G. H., Weiss S. T., Postma D. S. Lack of correlation between bronchoconstrictor response and bronchodilator response in a population-based study. Eur Respir J. 1997 Dec;10(12):2772–2777. doi: 10.1183/09031936.97.10122772. [DOI] [PubMed] [Google Scholar]
  10. Ebi-Kryston K. L. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol. 1988;41(3):251–260. doi: 10.1016/0895-4356(88)90129-1. [DOI] [PubMed] [Google Scholar]
  11. Hamerman D. Toward an understanding of frailty. Ann Intern Med. 1999 Jun 1;130(11):945–950. doi: 10.7326/0003-4819-130-11-199906010-00022. [DOI] [PubMed] [Google Scholar]
  12. Hansen E. F., Phanareth K., Laursen L. C., Kok-Jensen A., Dirksen A. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1267–1271. doi: 10.1164/ajrccm.159.4.9807121. [DOI] [PubMed] [Google Scholar]
  13. Hospers J. J., Postma D. S., Rijcken B., Weiss S. T., Schouten J. P. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet. 2000 Oct 14;356(9238):1313–1317. doi: 10.1016/S0140-6736(00)02815-4. [DOI] [PubMed] [Google Scholar]
  14. Hospers J. J., Rijcken B., Schouten J. P., Postma D. S., Weiss S. T. Eosinophilia and positive skin tests predict cardiovascular mortality in a general population sample followed for 30 years. Am J Epidemiol. 1999 Sep 1;150(5):482–491. doi: 10.1093/oxfordjournals.aje.a010037. [DOI] [PubMed] [Google Scholar]
  15. Hospers J. J., Schouten J. P., Weiss S. T., Postma D. S., Rijcken B. Eosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sample. Epidemiology. 2000 May;11(3):261–268. doi: 10.1097/00001648-200005000-00006. [DOI] [PubMed] [Google Scholar]
  16. Kanner R. E. The relationship between airways responsiveness and chronic airflow limitation. Chest. 1984 Jul;86(1):54–57. doi: 10.1378/chest.86.1.54. [DOI] [PubMed] [Google Scholar]
  17. Lange P., Nyboe J., Appleyard M., Jensen G., Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax. 1990 Aug;45(8):579–585. doi: 10.1136/thx.45.8.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lange P., Parner J., Vestbo J., Schnohr P., Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998 Oct 22;339(17):1194–1200. doi: 10.1056/NEJM199810223391703. [DOI] [PubMed] [Google Scholar]
  19. Lange P., Ulrik C. S., Vestbo J. Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet. 1996 May 11;347(9011):1285–1289. doi: 10.1016/s0140-6736(96)90937-x. [DOI] [PubMed] [Google Scholar]
  20. Peat J. K., Salome C. M., Xuan W. On adjusting measurements of airway responsiveness for lung size and airway caliber. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):870–875. doi: 10.1164/ajrccm.154.4.8887577. [DOI] [PubMed] [Google Scholar]
  21. Peat J. K., Woolcock A. J., Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis. 1987 Mar;70(3):171–179. [PubMed] [Google Scholar]
  22. Peto R., Speizer F. E., Cochrane A. L., Moore F., Fletcher C. M., Tinker C. M., Higgins I. T., Gray R. G., Richards S. M., Gilliland J. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis. 1983 Sep;128(3):491–500. doi: 10.1164/arrd.1983.128.3.491. [DOI] [PubMed] [Google Scholar]
  23. Postma D. S., Gimeno F., van der Weele L. T., Sluiter H. J. Assessment of ventilatory variables in survival prediction of patients with chronic airflow obstruction: the importance of reversibility. Eur J Respir Dis. 1985 Nov;67(5):360–368. [PubMed] [Google Scholar]
  24. Postma D. S., de Vries K., Koëter G. H., Sluiter H. J. Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis. 1986 Aug;134(2):276–280. doi: 10.1164/arrd.1986.134.2.276. [DOI] [PubMed] [Google Scholar]
  25. Rutgers S. R., Koëter G. H., van der Mark T. W., Postma D. S. Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):880–886. doi: 10.1164/ajrccm.157.3.9709100. [DOI] [PubMed] [Google Scholar]
  26. Tashkin D. P., Altose M. D., Connett J. E., Kanner R. E., Lee W. W., Wise R. A. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1802–1811. doi: 10.1164/ajrccm.153.6.8665038. [DOI] [PubMed] [Google Scholar]
  27. Ulrik C. S., Backer V., Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax. 1992 Jan;47(1):14–18. doi: 10.1136/thx.47.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Vestbo J., Knudsen K. M., Rasmussen F. V. The value of mucus hypersecretion as a predictor of mortality and hospitalization. An 11-year register based follow-up study of a random population sample of 876 men. Respir Med. 1989 May;83(3):207–211. doi: 10.1016/s0954-6111(89)80033-2. [DOI] [PubMed] [Google Scholar]
  29. Vestbo J., Prescott E. Update on the "Dutch hypothesis" for chronic respiratory disease. Thorax. 1998 Aug;53 (Suppl 2):S15–S19. doi: 10.1136/thx.53.2008.s15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Vollmer W. M., Johnson L. R., Buist A. S. Relationship of response to a bronchodilator and decline in forced expiratory volume in one second in population studies. Am Rev Respir Dis. 1985 Dec;132(6):1186–1193. doi: 10.1164/arrd.1985.132.6.1186. [DOI] [PubMed] [Google Scholar]
  31. Walston J., Fried L. P. Frailty and the older man. Med Clin North Am. 1999 Sep;83(5):1173–1194. doi: 10.1016/s0025-7125(05)70157-7. [DOI] [PubMed] [Google Scholar]
  32. Wiles F. J., Hnizdo E. Relevance of airflow obstruction and mucus hypersecretion to mortality. Respir Med. 1991 Jan;85(1):27–35. doi: 10.1016/s0954-6111(06)80207-6. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES